An epithelial armamentarium to sense the microbiota

Seminars in Immunology

Volumn 25, Issue 5, 2013, Pages 323-333

  Prescott, David ^a   Lee, Jooeun ^a   Philpott, Dana J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Intestinal epithelial cells; Microbiota; Nod like receptors; Pattern recognition receptors; Toll like receptors

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CHEMOKINE RECEPTOR CCR9; INTERLEUKIN 10; INTERLEUKIN 6; KERATINOCYTE GROWTH FACTOR; PATTERN RECOGNITION RECEPTOR; SECRETORY IMMUNOGLOBULIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; UVOMORULIN;

APOPTOSIS; CAMPYLOBACTER JEJUNI; CD4+ T LYMPHOCYTE; CELL INTERACTION; CLOSTRIDIUM DIFFICILE; DENDRITIC CELL; HELICOBACTER PYLORI; HUMAN; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; INTRACELLULAR SIGNALING; MONONUCLEAR PHAGOCYTE; NONHUMAN; REVIEW; VIBRIO CHOLERAE;

INTESTINAL EPITHELIAL CELLS; MICROBIOTA; NOD-LIKE RECEPTORS; PATTERN RECOGNITION RECEPTORS; TOLL-LIKE RECEPTORS;

ANIMALS; BACTERIA; HUMANS; INTESTINAL MUCOSA; MICROBIOTA; RECEPTORS, PATTERN RECOGNITION;

EID: 84888866750     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2013.09.007     Document Type: Review

References (196)

1. Mowat A.M., Viney J.L. The anatomical basis of intestinal immunity. Immunological Reviews 1997, 156:145-166.
2. O'Hara A.M., Shanahan F. The gut flora as a forgotten organ. EMBO Reports 2006, 7:688-693.
3. Kim Y.S., Ho S.B. Intestinal goblet cells and mucins in health and disease: recent insights and progress. Current Gastroenterology Reports 2010, 12:319-330.
4. McDole J.R., Wheeler L.W., McDonald K.G., Wang B., Konjufca V., Knoop K.A., et al. Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine. Nature 2012, 483:345-349.
5. Clevers H.C., Bevins C.L. Paneth cells: maestros of the small intestinal crypts. Annual Review of Physiology 2013, 75:289-311.
6. Gerbe F., Legraverend C., Jay P. The intestinal epithelium tuft cells: specification and function. Cellular and Molecular Life Sciences: CMLS 2012, 69:2907-2917.
7. Barker N., van Es J.H., Kuipers J., Kujala P., van den Born M., Cozijnsen M., et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449:1003-1007.
8. Cheng H., Leblond C.P. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine V. Unitarian Theory of the origin of the four epithelial cell types. American Journal of Anatomy 1974, 141:537-561.
9. Robertson S.J., Girardin S.E. Nod-like receptors in intestinal host defense: controlling pathogens, the microbiota, or both?. Current Opinion in Gastroenterology 2012, 29:15-22.
10. Oda K., Kitano H. A comprehensive map of the toll-like receptor signaling network. Molecular Systems Biology 2006, 2.
11. Otte J.-M., Cario E., Podolsky D.K. Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 2004, 126:1054-1070.
12. Cario E., Podolsky D.K. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infection and Immunity 2000, 68:7010-7017.
13. Suzuki M., Hisamatsu T., Podolsky D.K. Gamma interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular Toll-like receptor 4-MD-2 complex. Infection and Immunity 2003, 71:3503-3511.
14. Abreu M.T., Arnold E.T., Thomas L.S., Gonsky R., Zhou Y., Hu B., et al. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. Journal of Biological Chemistry 2002, 277:2043-2047.
15. Ewaschuk J.B., Backer J.L., Churchill T.A., Obermeier F., Krause D.O., Madsen K.L. Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA. Infection and Immunity 2007, 75:2572-2579.
16. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
17. Vaishnava S., Yamamoto M., Severson K.M., Ruhn K.A., Yu X., Koren O., et al. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science (New York, NY) 2011, 334:255-258.
18. Frantz A.L., Rogier E.W., Weber C.R., Shen L., Cohen D.A., Fenton L.A., et al. Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin-2, and antibacterial peptides. Mucosal Immunology 2012, 5:501-512.
19. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001, 411:603-606.
20. Gong J., Xu J., Zhu W., Gao X., Li N., Li J. Epithelial-specific blockade of MyD88-dependent pathway causes spontaneous small intestinal inflammation. Clinical Immunology (Orlando, FL) 2010, 136:245-256.
21. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cézard J.P., Belaiche J., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411:599-603.
22. Hisamatsu T., Suzuki M., Podolsky D.K. Interferon-gamma augments CARD4/NOD1 gene and protein expression through interferon regulatory factor-1 in intestinal epithelial cells. Journal of Biological Chemistry 2003, 278:3296-3298.
23. Brandl K., Sun L., Neppl C., Siggs O.M., Le Gall S.M., Tomisato W., et al. MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:1996-2072.
24. Nenci A., Becker C., Wullaert A., Gareus R., van Loo G., Danese S., et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007, 446:557-561.
25. Zaph C., Troy A.E., Taylor B.C., Berman-Booty L.D., Guild K.J., Du Y., et al. Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis. Nature 2007, 446:552-556.
26. Vora P., Youdim A., Thomas L.S., Fukata M., Tesfay S.Y., Lukasek K., et al. Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells. Journal of Immunology (Baltimore, Md.: 1950) 2004, 173:5398-5405.
27. Ayabe T., Satchell D.P., Wilson C.L., Parks W.C., Selsted M.E., Ouellette A.J. Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nature Immunology 2000, 1:113-118.
28. Hu G., Gong A.-Y., Roth A.L., Huang B.Q., Ward H.D., Zhu G., et al. Release of luminal exosomes contributes to TLR4-mediated epithelial antimicrobial defense. PLoS Pathogens 2013, 9:e1003-e1261.
29. Fukata M., Michelsen K.S., Eri R., Thomas L.S., Hu B., Lukasek K., et al. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. American Journal of Physiology. Gastrointestinal and Liver Physiology 2005, 288:1055-1065.
30. Ungaro R., Fukata M., Hsu D., Hernandez Y., Breglio K., Chen A., et al. A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. American Journal of Physiology. Gastrointestinal and Liver Physiology 2009, 296:1167-1179.
31. Fukata M., Chen A., Klepper A., Krishnareddy S., Vamadevan A.S., Thomas L.S., et al. Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology 2006, 131:862-877.
32. Morteau O., Morham S.G., Sellon R., Dieleman L.A., Langenbach R., Smithies O., et al. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. Journal of Clinical Investigation 2000, 105:469-478.
33. Hsu D., Fukata M., Hernandez Y.G., Sotolongo J.P., Goo T., Maki J., et al. Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury. Laboratory Investigation; A Journal of Technical Methods and Pathology 2010, 90:1295-1305.
34. McElroy S.J., Hobbs S., Kallen M., Tejera N., Rosen M.J., Grishin A., et al. Transactivation of EGFR by LPS induces COX-2 expression in enterocytes. PLoS ONE 2012, 7:e38373.
35. Hernandez Y., Sotolongo J., Breglio K., Conduah D., Chen A., Xu R., et al. The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia. BMC Gastroenterology 2010, 10:82.
36. Fukata M., Chen A., Vamadevan A.S., Cohen J., Breglio K., Krishnareddy S., et al. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 2007, 133:1869-1881.
37. Fukata M., Shang L., Santaolalla R., Sotolongo J., Pastorini C., España C., et al. Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis. Inflammatory Bowel Diseases 2011, 17:1464-1473.
38. Khan M.A., Ma C., Knodler L.A., Valdez Y., Rosenberger C.M., Deng W., et al. Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice. Infection and Immunity 2006, 74:2522-2536.
39. Leaphart C.L., Cavallo J., Gribar S.C., Cetin S., Li J., Branca M.F., et al. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. Journal of Immunology (Baltimore, Md.: 1950) 2007, 179:4808-4820.
40. Sodhi C.P., Neal M.D., Siggers R., Sho S., Ma C., Branca M.F., et al. Intestinal epithelial Toll-like receptor 4 regulates goblet cell development and is required for necrotizing enterocolitis in mice. Gastroenterology 2012, 143. 708-18.e1-5.
41. Neal M.D., Sodhi C.P., Dyer M., Craig B.T., Good M., Jia H., et al. A critical role for TLR4 induction of autophagy in the regulation of enterocyte migration and the pathogenesis of necrotizing enterocolitis. Journal of Immunology (Baltimore, Md.: 1950) 2013, 190:3451-3551.
42. Aliprantis A.O., Yang R.B., Mark M.R., Suggett S., Devaux B., Radolf J.D., et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science (New York, NY) 1999, 285:736-739.
43. Takeuchi O., Kawai T., Mühlradt P.F., Morr M., Radolf J.D., Zychlinsky A., et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. International Immunology 2001, 13:933-940.
44. Takeuchi O., Sato S., Horiuchi T., Hoshino K., Takeda K., Dong Z., et al. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. Journal of Immunology (Baltimore, Md.: 1950) 2002, 169:10-14.
45. Furrie E., Macfarlane S., Thomson G., Macfarlane G.T. Toll-like receptors-2 -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology 2005, 115:565-574. Microbiology & Gut Biology Group, Tayside Tissue & Tumour Bank.
46. Chabot S., Wagner J.S., Farrant S., Neutra M.R. TLRs regulate the gatekeeping functions of the intestinal follicle-associated epithelium. Journal of Immunology (Baltimore, Md.: 1950) 2006, 176:4275-4283.
47. Pierik M., Joossens S., Van Steen K., Van Schuerbeek N., Vlietinck R., Rutgeerts P., et al. Toll-like receptor-1 -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflammatory Bowel Diseases 2006, 12:1-8.
48. Podolsky D.K., Gerken G., Eyking A., Cario E. Colitis-associated variant of TLR2 causes impaired mucosal repair because of TFF3 deficiency. Gastroenterology 2009, 137:209-220.
49. Lowe E.L., Crother T.R., Rabizadeh S., Hu B., Wang H., Chen S., et al. Toll-like receptor 2 signaling protects mice from tumor development in a mouse model of colitis-induced cancer. PLoS ONE 2010, 5:e13027.
50. Ey B., Eyking A., Klepak M., Salzman N.H., Göthert J.R., Rünzi M., et al. Loss of TLR2 worsens spontaneous colitis in MDR1A deficiency through commensally induced pyroptosis. Journal of Immunology (Baltimore, Md.: 1950) 2013, 190:5676-5688.
51. Gibson D.L., Ma C., Rosenberger C.M., Bergstrom K.S.B., Valdez Y., Huang J.T., et al. Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis. Cellular Microbiology 2007, 10:388-403.
52. Gibson D.L., Montero M., Ropeleski M.J., Bergstrom K.S.B., Ma C., Ghosh S., et al. Interleukin-11 reduces TLR4-induced colitis in TLR2-deficient mice and restores intestinal STAT3 signaling. Gastroenterology 2010, 139:1277-1288.
53. Watanabe T., Kitani A., Murray P.J., Wakatsuki Y., Fuss I.J., Strober W. Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis. Immunity 2006, 25:473-485.
54. Cario E., Gerken G., Podolsky D.K. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 2004, 127:224-238.
55. Cario E., Gerken G., Podolsky D.K. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 2007, 132:1359-1374.
56. Ey B., Eyking A., Gerken G., Podolsky D.K., Cario E. TLR2 mediates gap junctional intercellular communication through connexin-43 in intestinal epithelial barrier injury. Journal of Biological Chemistry 2009, 284:22332-22343.
57. Hayashi F., Smith K.D., Ozinsky A., Hawn T.R., Yi E.C., Goodlett D.R., et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001, 410:1099-1103.
58. Gewirtz A.T., Navas T.A., Lyons S., Godowski P.J., Madara J.L. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. Journal of Immunology (Baltimore, Md.: 1950) 2001, 167:1882-1885.
59. Bambou J.-C., Giraud A., Ménard S., Begue B., Rakotobe S., Heyman M., et al. In vitro and ex vivo activation of the TLR5 signaling pathway in intestinal epithelial cells by a commensal Escherichia coli strain. Journal of Biological Chemistry 2004, 279:42984-42992.
60. Tallant T., Deb A., Kar N., Lupica J., de Veer M.J., DiDonato J.A. Flagellin acting via TLR5 is the major activator of key signaling pathways leading to NF-κB and proinflammatory gene program activation in intestinal epithelial cells. BMC Microbiology 2004, 4:33.
61. Rhee S.H., Kim H., Moyer M.P., Pothoulakis C. Role of MyD88 in phosphatidylinositol 3-kinase activation by flagellin/toll-like receptor 5 engagement in colonic epithelial cells. Journal of Biological Chemistry 2006, 281:18560-18568.
62. Choi Y.J., Im E., Chung H.K., Pothoulakis C., Rhee S.H. TRIF mediates Toll-like receptor 5-induced signaling in intestinal epithelial cells. Journal of Biological Chemistry 2010, 285:37570-37578.
63. Eaves-Pyles T., Bu H.-F., Tan X.-D., Cong Y., Patel J., Davey R.A., et al. Luminal-applied flagellin is internalized by polarized intestinal epithelial cells and elicits immune responses via the TLR5 dependent mechanism. PLoS ONE 2011, 6:e24869.
64. Im E., Jung J., Rhee S.H. Toll-like receptor 5 engagement induces interleukin-17C expression in intestinal epithelial cells. Journal of Interferon and Cytokine Research: The Official Journal of the International Society for Interferon and Cytokine Research 2012, 32:583-591.
65. Lodes M.J., Cong Y., Elson C.O., Mohamath R., Landers C.J., Targan S.R., et al. Bacterial flagellin is a dominant antigen in Crohn disease. Journal of Clinical Investigation 2004, 113:1296-1306.
66. Gewirtz A.T. Intestinal epithelial toll-like receptors: to protect. And serve?. Current Pharmaceutical Design 2003, 9:1-5.
67. Gewirtz A.T., Vijay-Kumar M., Brant S.R., Duerr R.H., Nicolae D.L., Cho J.H. Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn's disease. American Journal of Physiology. Gastrointestinal and Liver Physiology 2006, 290:G1157-G1163.
68. Sheridan J., Mack D.R., Amre D.K., Israel D.M., Cherkasov A., Li H., et al. A non-synonymous coding variant (L616F) in the TLR5 gene is potentially associated with Crohn's disease and influences responses to bacterial flagellin. PLoS ONE 2013, 8:e61326.
69. Hardenberg G., Yao Y., Piccirillo C.A., Levings M.K., Steiner T.S. Toll-like receptor 5 deficiency protects from wasting disease in a T cell transfer colitis model in T cell receptor-β-deficient mice. Inflammatory Bowel Diseases 2012, 18:85-93.
70. Carvalho F.A., Barnich N., Sauvanet P., Darcha C., Gelot A., Darfeuille-Michaud A. Crohn's disease-associated Escherichia coli LF82 aggravates colitis in injured mouse colon via signaling by flagellin. Inflammatory Bowel Diseases 2008, 14:1051-1060.
71. Boudeau J., Glasser A.L., Masseret E., Joly B., Darfeuille-Michaud A. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infection and Immunity 1999, 67:4499-4509.
72. Ivison S.M., Himmel M.E., Hardenberg G., Wark P.A.J., Kifayet A., Levings M.K., et al. TLR5 is not required for flagellin-mediated exacerbation of DSS colitis. Inflammatory Bowel Diseases 2010, 16:401-409.
73. Vijay-Kumar M., Sanders C.J., Taylor R.T., Kumar A., Aitken J.D., Sitaraman S.V., et al. Deletion of TLR5 results in spontaneous colitis in mice. Journal of Clinical Investigation 2007, 117:3909-3921.
74. Carvalho F.A., Koren O., Goodrich J.K., Johansson M.E.V., Nalbantoglu I., Aitken J.D., et al. Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host and Microbe 2012, 12:139-152.
75. Vijay-Kumar M., Wu H., Jones R., Grant G., Babbin B., King T.P., et al. Flagellin suppresses epithelial apoptosis and limits disease during enteric infection. American Journal of Pathology 2006, 169:1686-1700.
76. Carvalho F.A., Aitken J.D., Gewirtz A.T., Vijay-Kumar M. TLR5 activation induces secretory interleukin-1 receptor antagonist (sIL-1Ra) and reduces inflammasome-associated tissue damage. Mucosal Immunology 2010, 4:102-111.
77. Arend W.P., Gabay C. Physiologic role of interleukin-1 receptor antagonist. Arthritis Research 2000, 2:245-248.
78. Carvalho F.A., Nalbantoglu I., Ortega-Fernandez S., Aitken J.D., Su Y., Koren O., et al. Interleukin-1β (IL-1β) promotes susceptibility of Toll-like receptor 5 (TLR5) deficient mice to colitis. Gut 2012, 61:373-384.
79. Miao E.A., Alpuche-Aranda C.M., Dors M., Clark A.E., Bader M.W., Miller S.I., et al. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nature Immunology 2006, 7:569-575.
80. Lightfield K.L., Persson J., Brubaker S.W., Witte C.E., Moltke von J., Dunipace E.A., et al. Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellin. Nature Immunology 2008, 9:1171-1178.
81. Fink S.L., Cookson B.T. Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cellular Microbiology 2006, 8:1812-1825.
82. Hu B., Elinav E., Huber S., Booth C.J., Strowig T., Jin C., et al. Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:21635-21640.
83. Franchi L., Kamada N., Nakamura Y., Burberry A., Kuffa P., Suzuki S., et al. NLRC4-driven production of IL-1β discriminates between pathogenic and commensal bacteria and promotes host intestinal defense. Nature Immunology 2012, 13:449-456.
84. Carvalho F.A., Nalbantoglu I., Aitken J.D., Uchiyama R., Su Y., Doho G.H., et al. Cytosolic flagellin receptor NLRC4 protects mice against mucosal and systemic challenges. Mucosal Immunology 2012, 5:288-298.
85. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
86. Stacey K.J., Young G.R., Clark F., Sester D.P., Roberts T.L., Naik S., et al. The molecular basis for the lack of immunostimulatory activity of vertebrate DNA. Journal of Immunology (Baltimore, Md.: 1950) 2003, 170:3614-3620.
87. Latz E., Schoenemeyer A., Visintin A., Fitzgerald K.A., Monks B.G., Knetter C.F., et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nature Immunology 2004, 5:190-198.
88. Lee J., Mo J.-H., Katakura K., Alkalay I., Rucker A.N., Liu Y.-T., et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nature Cell Biology 2006, 8:1327-1336.
89. Ghadimi D., Vrese M.de, Heller K.J., Schrezenmeir J. Effect of natural commensal-origin DNA on toll-like receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and barrier integritiy of polarized intestinal epithelial cells. Inflammatory Bowel Diseases 2010, 16:410-427.
90. de Kivit S., van Hoffen E., Korthagen N., Garssen J., Willemsen L.E.M., Apical T.L.R. ligation of intestinal epithelial cells drives a Th1-polarized regulatory or inflammatory type effector response in vitro. Immunobiology 2011, 216:518-527.
91. Rachmilewitz D., Karmeli F., Takabayashi K., Hayashi T., Leider-Trejo L., Lee J., et al. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 2002, 122:1428-1441.
92. Rachmilewitz D., Katakura K., Karmeli F., Hayashi T., Reinus C., Rudensky B., et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004, 126:520-528.
93. Rosenstiel P. Stories of love and hate. Current Opinion in Gastroenterology 2013, 29:125-132.
94. Katakura K., Lee J., Rachmilewitz D., Li G., Eckmann L., Raz E. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. Journal of Clinical Investigation 2005, 115:695-702.
95. Sodhi C., Levy R., Gill R., Neal M.D., Richardson W., Branca M., et al. DNA attenuates enterocyte Toll-like receptor 4-mediated intestinal mucosal injury after remote trauma. American Journal of Physiology. Gastrointestinal and Liver Physiology 2011, 300:G862-G873.
96. Rose W.A., Sakamoto K., Leifer C.A. TLR9 is important for protection against intestinal damage and for intestinal repair. Scientific Reports 2012, 2:574.
97. Sato T., Yamamoto M., Shimosato T., Klinman D.M. Accelerated wound healing mediated by activation of Toll-like receptor 9. Wound Repair and Regeneration: Official Publication of the Wound Healing Society [and] the European Tissue Repair Society 2010, 18:586-593.
98. Foureau D.M., Mielcarz D.W., Menard L.C., Schulthess J., Werts C., Vasseur V., et al. TLR9-dependent induction of intestinal alpha-defensins by Toxoplasma gondii. Journal of Immunology (Baltimore, Md.: 1950) 2010, 184:7022-7029.
99. Török H.-P., Glas J., Tonenchi L., Bruennler G., Folwaczny M., Folwaczny C. Crohn's disease is associated with a toll-like receptor-9 polymorphism. Gastroenterology 2004, 127:365-366.
100. Hisamatsu T., Suzuki M., Reinecker H.-C., Nadeau W.J., McCormick B.A., Podolsky D.K. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 2003, 124:993-1000.
101. Gutierrez O., Pipaon C., Inohara N., Fontalba A., Ogura Y., Prosper F., et al. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. Journal of Biological Chemistry 2002, 277:41701-41705.
102. Rosenstiel P., Fantini M., Bräutigam K., Kühbacher T., Waetzig G.H., Seegert D., et al. TNF-α and IFN-β regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 2003, 124:1001-1009.
103. Masumoto J., Yang K., Varambally S., Hasegawa M., Tomlins S.A., Qiu S., et al. Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo. Journal of Experimental Medicine 2006, 203:203-213.
104. Huang F.-C. Regulation of Salmonella flagellin-induced interleukin-8 in intestinal epithelial cells by muramyl dipeptide. Cellular Immunology 2012, 278:1-9.
105. Kim J.G., Lee S.J., Kagnoff M.F. Nod1 is an essential signal transducer in intestinal epithelial cells infected with bacteria that avoid recognition by toll-like receptors. Infection and Immunity 2004, 72:1487-1495.
106. Begue B., Dumant C., Bambou J.C., Beaulieu J.F., Chamaillard M., Hugot J.P., et al. Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop. Journal of Cellular Physiology 2006, 209:241-252.
107. Girardin S.E., Tournebize R., Mavris M., Page A.L., Li X., Stark G.R., et al. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Reports 2001, 2:736-742.
108. Viala J., Chaput C., Boneca I.G., Cardona A., Girardin S.E., Moran A.P., et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nature Immunology 2004, 5:1166-1174.
109. Hasegawa M., Yamazaki T., Kamada N., Tawaratsumida K., Kim Y.-G., Núñez G., et al. Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen. Journal of Immunology (Baltimore, Md.: 1950) 2011, 186:4872-4880.
110. Zilbauer M., Dorrell N., Elmi A., Lindley K.J., Schüller S., Jones H.E., et al. A major role for intestinal epithelial nucleotide oligomerization domain 1 (NOD1) in eliciting host bactericidal immune responses to Campylobacter jejuni. Cellular Microbiology 2007, 9:2404-2416.
111. Chatterjee D., Chaudhuri K. Vibrio cholerae O395 outer membrane vesicles modulate intestinal epithelial cells in a NOD1 protein-dependent manner and induce dendritic cell-mediated Th2/Th17 cell responses. Journal of Biological Chemistry 2013, 288:4299-4309.
112. Kobayashi K.S., Chamaillard M., Ogura Y., Henegariu O., Inohara N., Núñez G., et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science (New York, NY) 2005, 307:731-734.
113. Ogura Y., Lala S., Xin W., Smith E., Dowds T.A., Chen F.F., et al. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 2003, 52:1591-1597.
114. Lala S., Ogura Y., Osborne C., Hor S.Y., Bromfield A., Davies S., et al. Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology 2003, 125:47-57.
115. Rehman A., Sina C., Gavrilova O., Häsler R., Ott S., Baines J.F., et al. Nod2 is essential for temporal development of intestinal microbial communities. Gut 2011, 60:1354-1362.
116. Mondot S., Barreau F., Nabhani Al Z., Dussaillant M., Le Roux K., Doré J., et al. Altered gut microbiota composition in immune-impaired Nod2(-/-) mice. Gut 2012, 61:634-635.
117. Petnicki-Ocwieja T., Hrncir T., Liu Y.J., Biswas A., Hudcovic T., Tlaskalova-Hogenova H., et al. Nod2 is required for the regulation of commensal microbiota in the intestine. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:15813-15818.
118. Couturier-Maillard A., Secher T., Rehman A., Normand S., De Arcangelis A., Haesler R., et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. Journal of Clinical Investigation 2013, 123:700-711.
119. Robertson S.J., Zhou J.Y., Geddes K., Rubino S.J., Cho J.H., Girardin S.E., et al. Nod1 and Nod2 signaling does not alter the composition of intestinal bacterial communities at homeostasis. Gut Microbes 2013, 4:222-231.
120. Shanahan M.T., Carroll I.M., Grossniklaus E., White A., Furstenberg von R.J., Barner R., et al. Mouse Paneth cell antimicrobial function is independent of Nod2. Gut 2013.
121. Chen G.Y., Liu M., Wang F., Bertin J., Núñez G. A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. Journal of Immunology (Baltimore, Md.: 1950) 2011, 186:7187-7194.
122. Kempster S.L., Belteki G., Forhead A.J., Fowden A.L., Catalano R.D., Lam B.Y., et al. Developmental control of the Nlrp6 inflammasome and a substrate IL-18, in mammalian intestine. American Journal of Physiology. Gastrointestinal and Liver Physiology 2011, 300:G253-G263.
123. Normand S., Delanoye-Crespin A., Bressenot A., Huot L., Grandjean T., Peyrin-Biroulet L., et al. Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:9601-9606.
124. Elinav E., Strowig T., Kau A.L., Henao-Mejia J., Thaiss C.A., Booth C.J., et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011, 145:745-757.
125. Henao-Mejia J., Elinav E., Jin C., Hao L., Mehal W.Z., Strowig T., et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012, 482:179-185.
126. Sun Y., Zhang M., Chen C.C., Gillilland M., Sun X., Zaatari El M., et al. Stress-induced corticotropin-releasing hormone-mediated NLRP6 inflammasome inhibition and transmissible enteritis in mice. Gastroenterology 2013, 144:1478-1487.
127. Abreu M.T., Vora P., Faure E., Thomas L.S., Arnold E.T., Arditi M. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. Journal of Immunology (Baltimore, Md.: 1950) 2001, 167:1609-1616.
128. Vamadevan A.S., Fukata M., Arnold E.T., Thomas L.S., Hsu D., Abreu M.T. Regulation of Toll-like receptor 4-associated MD-2 in intestinal epithelial cells: a comprehensive analysis. Innate Immunity 2010, 16:93-103.
129. Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K., et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. Journal of Experimental Medicine 1999, 189:1777-1782.
130. Lenoir C., Sapin C., Broquet A.H., Jouniaux A.-M., Bardin S., Gasnereau I., et al. MD-2 controls bacterial lipopolysaccharide hyporesponsiveness in human intestinal epithelial cells. Life Sciences 2008, 82:519-528.
131. Seksik P., Sokol H., Grondin V., Adrie C., Duboc H., Pigneur B., et al. Sera from patients with Crohn's disease break bacterial lipopolysaccharide tolerance of human intestinal epithelial cells via MD-2 activity. Innate Immunity 2010, 16:381-390.
132. Didierlaurent A., Brissoni B., Velin D., Aebi N., Tardivel A., Käslin E., et al. Tollip regulates proinflammatory responses to interleukin-1 and lipopolysaccharide. Molecular and Cellular Biology 2006, 26:735-742.
133. Burns K., Clatworthy J., Martin L., Martinon F., Plumpton C., Maschera B., et al. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nature Cell Biology 2000, 2:346-351.
134. Melmed G., Thomas L.S., Lee N., Tesfay S.Y., Lukasek K., Michelsen K.S., et al. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. Journal of Immunology (Baltimore, Md.: 1950) 2003, 170:1406-1415.
135. Qin J., Qian Y., Yao J., Grace C., Li X. SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms. Journal of Biological Chemistry 2005, 280:25233-25241.
136. Kadota C., Ishihara S., Aziz M.M., Rumi M.A., Oshima N., Mishima Y., et al. Down-regulation of single immunoglobulin interleukin-1R-related molecule (SIGIRR)/TIR8 expression in intestinal epithelial cells during inflammation. Clinical and Experimental Immunology 2010, 162:348-361.
137. Xiao H., Gulen M.F., Qin J., Yao J., Bulek K., Kish D., et al. The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 2007, 26:461-475.
138. Lotz M. Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. Journal of Experimental Medicine 2006, 203:973-984.
139. Afrazi A., Sodhi C.P., Good M., Jia H., Siggers R., Yazji I., et al. Intracellular heat shock protein-70 negatively regulates TLR4 signaling in the newborn intestinal epithelium. Journal of Immunology (Baltimore, Md.: 1950) 2012, 188:4543-4557.
140. Wang J., Ford H.R., Grishin A.V. NF-kappaB-mediated expression of MAPK phosphatase-1 is an early step in desensitization to TLR ligands in enterocytes. Mucosal Immunology 2010, 3:523-534.
141. Wang J., Ouyang Y., Guner Y., Ford H.R., Grishin A.V. Ubiquitin-editing enzyme A20 promotes tolerance to lipopolysaccharide in enterocytes. Journal of Immunology (Baltimore, Md.: 1950) 2009, 183:1384-1392.
142. Chassin C., Kocur M., Pott J., Duerr C.U., Gütle D., Lotz M., et al. miR-146a mediates protective innate immune tolerance in the neonate intestine. Cell Host and Microbe 2010, 8:358-368.
143. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nature Reviews Immunology 2008, 8:411-420.
144. Rescigno M., Urbano M., Valzasina B., Francolini M., Rotta G., Bonasio R., et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nature Immunology 2001, 2:361-367.
145. Niess J.H., Brand S., Gu X., Landsman L., Jung S., McCormick B.A., et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science (New York, NY) 2005, 307:254-258.
146. Vallon-Eberhard A., Landsman L., Yogev N., Verrier B., Jung S. Transepithelial pathogen uptake into the small intestinal lamina propria. Journal of Immunology (Baltimore, Md.: 1950) 2006, 176:2465-2469.
147. Kim K.W., Vallon-Eberhard A., Zigmond E., Farache J., Shezen E., Shakhar G., et al. In vivo structure/function and expression analysis of the CX3C chemokine fractalkine. Blood 2011, 118:e156-e167.
148. Rivollier A., He J., Kole A., Valatas V., Kelsall B.L. Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. Journal of Experimental Medicine 2012, 209:139-155.
149. Varol C., Zigmond E., Jung S. Securing the immune tightrope: mononuclear phagocytes in the intestinal lamina propria. Nature Reviews Immunology 2010, 10:415-426.
150. Bogunovic M., Ginhoux F., Helft J., Shang L., Hashimoto D., Greter M., et al. Origin of the lamina propria dendritic cell network. Immunity 2009, 31:513-525.
151. Varol C., Vallon-Eberhard A., Elinav E., Aychek T., Shapira Y., Luche H., et al. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 2009, 31:502-512.
152. Schulz O., Jaensson E., Persson E.K., Liu X., Worbs T., Agace W.W., et al. Intestinal CD103+ but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. Journal of Experimental Medicine 2009, 206:3101-3114.
153. Niess J.H., Adler G. Enteric flora expands gut lamina propria CX3CR1+ dendritic cells supporting inflammatory immune responses under normal and inflammatory conditions. Journal of Immunology (Baltimore, Md.: 1950) 2010, 184:2026-2037.
154. Weber B., Saurer L., Schenk M., Dickgreber N., Mueller C. CX3CR1 defines functionally distinct intestinal mononuclear phagocyte subsets which maintain their respective functions during homeostatic and inflammatory conditions. European Journal of Immunology 2011, 41:773-779.
155. Hadis U., Wahl B., Schulz O., Hardtke-Wolenski M., Schippers A., Wagner N., et al. Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. Immunity 2011, 34:237-246.
156. Diehl G.E., Longman R.S., Zhang J.X., Breart B., Galan C., Cuesta A., et al. Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX(3)CR1(hi) cells. Nature 2013, 494:116-120.
157. Zigmond E., Varol C., Farache J., Elmaliah E., Satpathy A.T., Friedlander G., et al. Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity 2012, 37:1076-1090.
158. Fortin G., Raymond M., Van V.Q., Rubio M., Gautier P., Sarfati M., et al. A role for CD47 in the development of experimental colitis mediated by SIRPalpha+CD103- dendritic cells. Journal of Experimental Medicine 2009, 206:1995-2011.
159. Johansson-Lindbom B., Svensson M., Pabst O., Palmqvist C., Marquez G., Forster R., et al. Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing. Journal of Experimental Medicine 2005, 202:1063-1073.
160. Coombes J.L., Siddiqui K.R., Arancibia-Carcamo C.V., Hall J., Sun C.M., Belkaid Y., et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. Journal of Experimental Medicine 2007, 204:1757-1764.
161. Sun C.M., Hall J.A., Blank R.B., Bouladoux N., Oukka M., Mora J.R., et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3T reg cells via retinoic acid. Journal of Experimental Medicine 2007, 204:1775-1785.
162. Annacker O., Coombes J.L., Malmstrom V., Uhlig H.H., Bourne T., Johansson-Lindbom B., et al. Essential role for CD103 in the T cell-mediated regulation of experimental colitis. Journal of Experimental Medicine 2005, 202:1051-1061.
163. Worbs T., Bode U., Yan S., Hoffmann M.W., Hintzen G., Bernhardt G., et al. Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. Journal of Experimental Medicine 2006, 203:519-527.
164. Cerovic V., Houston S.A., Scott C.L., Aumeunier A., Yrlid U., Mowat A.M., et al. Intestinal CD103(-) dendritic cells migrate in lymph and prime effector T cells. Mucosal Immunology 2013, 6:104-113.
165. Kinnebrew M.A., Buffie C.G., Diehl G.E., Zenewicz L.A., Leiner I., Hohl T.M., et al. Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. Immunity 2012, 36:276-287.
166. Rimoldi M., Chieppa M., Larghi P., Vulcano M., Allavena P., Rescigno M. Monocyte-derived dendritic cells activated by bacteria or by bacteria-stimulated epithelial cells are functionally different. Blood 2005, 106:2818-2826.
167. Hanabuchi S., Ito T., Park W.R., Watanabe N., Shaw J.L., Roman E., et al. Thymic stromal lymphopoietin-activated plasmacytoid dendritic cells induce the generation of FOXP3+ regulatory T cells in human thymus. Journal of Immunology (Baltimore, Md.: 1950) 2010, 184:2999-3007.
168. Iliev I.D., Mileti E., Matteoli G., Chieppa M., Rescigno M. Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning. Mucosal Immunology 2009, 2:340-350.
169. Reardon C., Lechmann M., Brustle A., Gareau M.G., Shuman N., Philpott D., et al. Thymic stromal lymphopoetin-induced expression of the endogenous inhibitory enzyme SLPI mediates recovery from colonic inflammation. Immunity 2011, 35:223-235.
170. Rimoldi M., Chieppa M., Salucci V., Avogadri F., Sonzogni A., Sampietro G.M., et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nature Immunology 2005, 6:507-514.
171. Kang S., Okuno T., Takegahara N., Takamatsu H., Nojima S., Kimura T., et al. Intestinal epithelial cell-derived semaphorin 7A negatively regulates development of colitis via alphavbeta1 integrin. Journal of Immunology (Baltimore, Md.: 1950) 2012, 188:1108-1116.
172. Cheroutre H., Lambolez F., Mucida D. The light and dark sides of intestinal intraepithelial lymphocytes. Nature Reviews Immunology 2011, 11:445-456.
173. Beagley K.W., Fujihashi K., Lagoo A.S., Lagoo-Deenadaylan S., Black C.A., Murray A.M., et al. Differences in intraepithelial lymphocyte T cell subsets isolated from murine small versus large intestine. Journal of Immunology (Baltimore, Md.: 1950) 1995, 154:5611-5619.
174. Lundqvist C., Baranov V., Hammarstrom S., Athlin L., Hammarstrom M.L. Intra-epithelial lymphocytes. Evidence for regional specialization and extrathymic T cell maturation in the human gut epithelium. International Immunology 1995, 7:1473-1487.
175. Shires J., Theodoridis E., Hayday A.C. Biological insights into TCRgammadelta+ and TCRalphabeta+ intraepithelial lymphocytes provided by serial analysis of gene expression (SAGE). Immunity 2001, 15:419-434.
176. Tang F., Chen Z., Ciszewski C., Setty M., Solus J., Tretiakova M., et al. Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15. Journal of Experimental Medicine 2009, 206:707-719.
177. Mysorekar I.U., Lorenz R.G., Gordon J.I. A gnotobiotic transgenic mouse model for studying interactions between small intestinal enterocytes and intraepithelial lymphocytes. Journal of Biological Chemistry 2002, 277:37811-37819.
178. Puddington L., Olson S., Lefrancois L. Interactions between stem cell factor and c-Kit are required for intestinal immune system homeostasis. Immunity 1994, 1:733-739.
179. Cheroutre H., Madakamutil L. Acquired and natural memory T cells join forces at the mucosal front line. Nature Reviews Immunology 2004, 4:290-300.
180. Wurbel M.A., Philippe J.M., Nguyen C., Victorero G., Freeman T., Wooding P., et al. The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts double- and single-positive thymocytes expressing the TECK receptor CCR9. European Journal of Immunology 2000, 30:262-271.
181. Zabel B.A., Agace W.W., Campbell J.J., Heath H.M., Parent D., Roberts A.I., et al. Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis. Journal of Experimental Medicine 1999, 190:1241-1256.
182. Cepek K.L., Shaw S.K., Parker C.M., Russell G.J., Morrow J.S., Rimm D.L., et al. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature 1994, 372:190-193.
183. Kilshaw P.J., Murant S.J. A new surface antigen on intraepithelial lymphocytes in the intestine. European Journal of Immunology 1990, 20:2201-2207.
184. Cerf-Bensussan N., Jarry A., Brousse N., Lisowska-Grospierre B., Guy-Grand D., Griscelli C. A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes. European Journal of Immunology 1987, 17:1279-1285.
185. Komano H., Fujiura Y., Kawaguchi M., Matsumoto S., Hashimoto Y., Obana S., et al. Homeostatic regulation of intestinal epithelia by intraepithelial gamma delta T cells. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:6147-6151.
186. Yaguchi K., Kayaba S., Soga H., Yamagishi M., Tamura A., Kasahara S., et al. DNA fragmentation and detachment of enterocytes induced by anti-CD3 mAb-activated intraepithelial lymphocytes. Cell and Tissue Research 2004, 315:71-84.
187. Chen Y., Chou K., Fuchs E., Havran W.L., Boismenu R. Protection of the intestinal mucosa by intraepithelial gamma delta T cells. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:14338-14343.
188. Pabst O. New concepts in the generation and functions of IgA. Nature Reviews Immunology 2012, 12:821-832.
189. Moreau M.C., Ducluzeau R., Guy-Grand D., Muller M.C. Increase in the population of duodenal immunoglobulin A plasmocytes in axenic mice associated with different living or dead bacterial strains of intestinal origin. Infection and Immunity 1978, 21:532-539.
190. Bouskra D., Brézillon C., Bérard M., Werts C., Varona R., Boneca I.G., et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 2008, 456:507-510.
191. Tsuji M., Suzuki K., Kitamura H., Maruya M., Kinoshita K., Ivanov I.I., et al. Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin A generation in the gut. Immunity 2008, 29:261-271.
192. Shang L., Fukata M., Thirunarayanan N., Martin A.P., Arnaboldi P., Maussang D., et al. Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria. Gastroenterology 2008, 135:529-538.e1.
193. Goodrich M.E., McGee D.W. Effect of intestinal epithelial cell cytokines on mucosal B-cell IgA secretion: enhancing effect of epithelial-derived IL-6 but not TGF-beta on IgA+ B cells. Immunology Letters 1999, 67:11-14.
194. He B., Xu W., Santini P.A., Polydorides A.D., Chiu A., Estrella J., et al. Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 2007, 26:812-826.
195. Diebel L.N., Liberati D.M. Disparate effects of bacteria and Toll-like receptor-dependant bacterial ligand stimulation on immunoglobulin A transcytosis. Journal of Trauma 2011, 70:691-700.
196. Macpherson A.J., Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science (New York, NY) 2004, 303:1662-1665.